Sulfadimethoxine, a new long-acting sulfonamide; some preliminary clinical and laboratory observations in infants and children. 1958

S ROSS, and J R PUIG, and E A ZAREMBA

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077145 Sulfanilamide A short-acting sulfonamide used as an anti-infective agent. It has lower anti-bacterial activity than SULFAMETHOXAZOLE. 4-aminobenzenesulfonamide,Azol Polvo,Sulfanilamide Barium Salt,Sulfanilamide Cadmium Salt,Sulfanilamide Hydrochloride,Sulfanilamide Lithium Salt,Sulfanilamide Magnesium Salt,Sulfanilamide Monohydrate,Sulfanilamide Silver Salt,Sulfanilamide Sodium,Sulfanilamide Sodium Salt,Sulfanilamide Strontium Salt,Sulfanilamide Zinc Salt,Sulphanilamide,4 aminobenzenesulfonamide
D013412 Sulfadimethoxine A sulfanilamide that is used as an anti-infective agent. Deposul,Sulphadimethoxine
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell

Related Publications

S ROSS, and J R PUIG, and E A ZAREMBA
October 1957, Annals of the New York Academy of Sciences,
S ROSS, and J R PUIG, and E A ZAREMBA
January 1958, Antibiotics annual,
S ROSS, and J R PUIG, and E A ZAREMBA
August 1959, Schweizerische medizinische Wochenschrift,
S ROSS, and J R PUIG, and E A ZAREMBA
July 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S ROSS, and J R PUIG, and E A ZAREMBA
January 1960, The American journal of the medical sciences,
S ROSS, and J R PUIG, and E A ZAREMBA
April 1960, Minerva medica,
S ROSS, and J R PUIG, and E A ZAREMBA
April 1960, Minerva medica,
S ROSS, and J R PUIG, and E A ZAREMBA
September 1959, Annals of the New York Academy of Sciences,
S ROSS, and J R PUIG, and E A ZAREMBA
June 1958, Indian journal of medical sciences,
Copied contents to your clipboard!